Longer term, their pipeline has another second growth wave through mezagitamab, elritercept, fazirsiran, TAK-928, and TAK-921 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results